Home › Atherosclerosis › New Jersey › Edison
Atherosclerosis clinical trials in Edison, NJ
4 studies for Atherosclerosis are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Cardio Metabolic Institute, Somerset · 4 mi away
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- CardioMetabolic Collaborative Clinic, Somerset · 4 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Somerset · 4 mi away
- Research Site, Bridgewater · 14 mi away
Pelacarsen Roll-over Extension Program
RecruitingPhase 3
- Robert Wood Johnson Medical School, New Brunswick · 3 mi away
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Hialeah, FL8 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Dallas, TX7 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Las Vegas, NV7 studies
- Miami, FL7 studies
- The Woodlands, TX6 studies
Other studies in Edison
- Breast Cancer69 studies
- Non-Small Cell Lung Cancer47 studies
- Cancer (all types)33 studies
- Prostate Cancer30 studies
- Lung Cancer24 studies
- Colorectal Cancer24 studies
- Bladder Cancer22 studies
- Multiple Myeloma22 studies
- Acute Myeloid Leukemia21 studies
- Endometrial Cancer20 studies
- Ovarian Cancer20 studies
- Metastatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.